Parkinson's Disease: Treatment
Parkinson's Disease: Overview
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Depolarizing Blockers: Mechanism of Action
Depolarizing Blockers: Pharmocokinetics
Neural Regulation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 21, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Deepak Sachan1, Amit Yadav2, Dinesh Yadav2
1Department of Pediatrics, PGIMER, Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital, New Delhi, India. deepaksachan26@yahoo.com.
No abstract available in PubMed .
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021